StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.9 % BTX stock opened at $2.48 on Friday. The business’s 50-day simple moving average is $3.18. The company has a market capitalization of […]
Stock analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report issued on Thursday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 2.5 % Shares of BTX stock opened at $3.14 on Thursday. The stock has a market cap of $184.71 million, a […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a research report released on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance NYSE:BTX opened at $2.88 on Wednesday. The company’s fifty day moving average price is $3.42 and its 200-day moving average price is […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report published on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance BTX opened at $3.40 on Friday. The stock has a market capitalization of $199.96 million, a PE ratio of -1.50 and a beta of […]
Investment analysts at StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Rating) in a report issued on Sunday. The firm set a “hold” rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance NYSE BTX opened at $3.48 on Friday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year high […]